Brief: Microbix Secures Funded Drug Commercialization Agreement

Microbix Biosystems

16/05/2023 12:06

May 16 (Reuters) - Microbix Biosystems Inc  MBX.TO :
    * MICROBIX SECURES FUNDED DRUG COMMERCIALIZATION AGREEMENT
    * MICROBIX BIOSYSTEMS INC - AGREEMENT IS WITH SEQUEL PHARMA
    * MICROBIX BIOSYSTEMS -  AGREEMENT PROVIDES FOR SEQUEL TO
FUND,
WORK TO RETURN KINLYTIC TO U.S. FOR CLINICAL INDICATION OF
VENOUS CATHETER CLEARANCE
    * MICROBIX BIOSYSTEMS INC - CO WILL RECEIVE A CLOSING
PAYMENT OF
US$ 2.0 MILLION UNDER AGREEMENT
    * MICROBIX BIOSYSTEMS - SEQUEL, CO PREPARE FOR UPDATED
CONSULTATION FDA TO CONFIRM PRIOR REGULATORY GUIDANCE RECEIVED
BY MICROBIX REMAINS PERTINENT
    * MICROBIX BIOSYSTEMS INC - UPON A SATISFACTORY FDA
CONSULTATION,
SEQUEL WILL MAKE A FURTHER US$ 2.0 MILLION PAYMENT TO CO
    * MICROBIX BIOSYSTEMS INC - SHOULD FDA CONSULTATION BE
UNEXPECTEDLY NEGATIVE, SEQUEL MAY TERMINATE AGREEMENT AND RECOUP
US$ 1.0 MILLION OF CLOSING PAYMENT

Source text for Eikon:  ID:nGNX613fz9 
Further company coverage:  MBX.TO